Correlation Between Vor Biopharma and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vor Biopharma and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vor Biopharma and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vor Biopharma and Seres Therapeutics, you can compare the effects of market volatilities on Vor Biopharma and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vor Biopharma with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vor Biopharma and Seres Therapeutics.
Diversification Opportunities for Vor Biopharma and Seres Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Vor and Seres is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Vor Biopharma and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Vor Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vor Biopharma are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Vor Biopharma i.e., Vor Biopharma and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Vor Biopharma and Seres Therapeutics
Considering the 90-day investment horizon Vor Biopharma is expected to generate 4.48 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, Vor Biopharma is 1.28 times less risky than Seres Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 78.00 in Seres Therapeutics on September 3, 2024 and sell it today you would earn a total of 20.00 from holding Seres Therapeutics or generate 25.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vor Biopharma vs. Seres Therapeutics
Performance |
| Timeline |
| Vor Biopharma |
| Seres Therapeutics |
Vor Biopharma and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vor Biopharma and Seres Therapeutics
The main advantage of trading using opposite Vor Biopharma and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vor Biopharma position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Vor Biopharma vs. DiaMedica Therapeutics | Vor Biopharma vs. Lyra Therapeutics | Vor Biopharma vs. Centessa Pharmaceuticals PLC |
| Seres Therapeutics vs. DiaMedica Therapeutics | Seres Therapeutics vs. Lyra Therapeutics | Seres Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |